These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35875673)

  • 1. Identification of Candidate Genes Associated With Prognosis in Glioblastoma.
    Li R; Jiang Q; Tang C; Chen L; Kong D; Zou C; Lin Y; Luo J; Zou D
    Front Mol Neurosci; 2022; 15():913328. PubMed ID: 35875673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and potential mechanism of AEBP1 in glioblastoma.
    Wang C; Han H; Cheng F; Wang H; Wang J; Lv C; Jiang S; Peng Y; Zhao X
    J Neuropathol Exp Neurol; 2024 Dec; 83(12):1020-1029. PubMed ID: 39190880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
    Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
    Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma.
    Zhang Y; Fan H; Zou C; Wei F; Sun J; Shang Y; Chen L; Wang X; Hu B
    Front Genet; 2022; 13():924802. PubMed ID: 36035134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma.
    Wei L; Zou C; Chen L; Lin Y; Liang L; Hu B; Mao Y; Zou D
    Front Mol Biosci; 2022; 9():876603. PubMed ID: 35573726
    [No Abstract]   [Full Text] [Related]  

  • 6. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma.
    Yuan Q; Zuo FX; Cai HQ; Qian HP; Wan JH
    Front Genet; 2022; 13():912227. PubMed ID: 35873494
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
    Lai W; Li D; Kuang J; Deng L; Lu Q
    Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
    Li L; Liu X; Ma X; Deng X; Ji T; Hu P; Wan R; Qiu H; Cui D; Gao L
    Exp Ther Med; 2019 Nov; 18(5):3439-3449. PubMed ID: 31602219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Immune-Related Prognostic Risk Model in Glioblastoma.
    Lin Z; Wang R; Huang C; He H; Ouyang C; Li H; Zhong Z; Guo J; Chen X; Yang C; Yang X
    Front Genet; 2022; 13():926122. PubMed ID: 35783263
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
    Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
    Front Genet; 2019; 10():419. PubMed ID: 31130992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.
    Hou X; Chen J; Zhang Q; Fan Y; Xiang C; Zhou G; Cao F; Yao S
    Exp Ther Med; 2021 Jan; 21(1):61. PubMed ID: 33365061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.